CORD-19:35349bb1fc9290338907b7d7f104c9db3951163b / 292554-292680 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/35349bb1fc9290338907b7d7f104c9db3951163b","sourcedb":"CORD-19","sourceid":"35349bb1fc9290338907b7d7f104c9db3951163b","text":"Transcutaneous half-life (tHL) was measured in parallel using a fluorescent marker (FITC-sinistrin) and the NIC-kidney device.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2127","span":{"begin":0,"end":126},"obj":"Sentence"},{"id":"T73501","span":{"begin":0,"end":126},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T2127","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T73501","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T608","span":{"begin":112,"end":118},"obj":"Body_part"}],"attributes":[{"id":"A608","pred":"uberon_id","subj":"T608","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"subj":"T608","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ecdd93","default":true},{"id":"CORD-19-PD-UBERON","color":"#c293ec"}]}]}}